Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of inflammation in the biology of myeloproliferative neoplasms
Steffen Koschmieder, Nicolas Chatain
Blood Reviews (2020) Vol. 42, pp. 100711-100711
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms
Chiara Baldini, Francesca Romana Moriconi, Sara Galimberti, et al.
European Heart Journal (2021) Vol. 42, Iss. 42, pp. 4389-4400
Open Access | Times Cited: 110
Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease
Ahmed A. Z. Dawoud, Rodney D. Gilbert, William Tapper, et al.
Leukemia (2021) Vol. 36, Iss. 2, pp. 507-515
Open Access | Times Cited: 66
Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms
Zhu Shen, Wenfei Du, Cecelia Perkins, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 10, pp. 100425-100425
Open Access | Times Cited: 44
Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in Adults
Yulia S. Panina, Elena E. Timechko, A. А. Usoltseva, et al.
Metabolites (2023) Vol. 13, Iss. 1, pp. 83-83
Open Access | Times Cited: 18
Moving toward disease modification in polycythemia vera
Jan Philipp Bewersdorf, Joan How, Lucia Masárová, et al.
Blood (2023) Vol. 142, Iss. 22, pp. 1859-1870
Closed Access | Times Cited: 16
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Guillermo Ortí, Luuk Gras, Nienke Zinger, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 4, pp. 628-638
Open Access | Times Cited: 14
Differential inflammatory conditioning of the bone marrow by acute myeloid leukemia and its impact on progression
Valentina R. Minciacchi, Christina Karantanou, Jimena Bravo, et al.
Blood Advances (2024) Vol. 8, Iss. 19, pp. 4983-4996
Open Access | Times Cited: 5
Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies
Vincenzo Nasillo, Giovanni Riva, Ambra Paolini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1906-1906
Open Access | Times Cited: 28
Recent Advances in Single-Cell View of Mesenchymal Stem Cell in Osteogenesis
Fangyuan Shen, Yu Shi
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 19
Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation
Wenjuan Fan, Weijie Cao, Jianxiang Shi, et al.
Annals of Hematology (2023) Vol. 102, Iss. 7, pp. 1745-1759
Open Access | Times Cited: 12
Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms
Peiwen Zhang, Na You, Yiyi Ding, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Research trends in essential thrombocythemia from 2001 to 2024: a bibliometric analysis
Yiming Pan, Lingyan Chen, Qun Jiang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Maike Büttner‐Herold, Carsten Sticht, Thorsten Wiech, et al.
Histopathology (2020) Vol. 78, Iss. 5, pp. 738-748
Open Access | Times Cited: 30
Insights into the Potential Mechanisms of JAK2V617F Somatic Mutation Contributing Distinct Phenotypes in Myeloproliferative Neoplasms
Panhong Gou, Wenchao Zhang, Stéphane Giraudier
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1013-1013
Open Access | Times Cited: 16
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis
Rong Li, M. Colombo, Guanlin Wang, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 768
Open Access | Times Cited: 3
<i>ASXL1</i> mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms
Zhongxun Shi, Jinqin Liu, Yingying Zhao, et al.
Haematologica (2022) Vol. 108, Iss. 5, pp. 1359-1373
Open Access | Times Cited: 15
Remodeling the Bone Marrow Microenvironment – A Proposal for Targeting Pro-inflammatory Contributors in MPN
Jonas S. Jutzi, Ann Mullally
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 20
Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms
Vibe Skov, Mads Thomassen, Lasse Kjær, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0270669-e0270669
Open Access | Times Cited: 12
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
Duc Tran, J. Scott Beeler, Jie Liu, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 15, pp. 3220-3228
Open Access | Times Cited: 2
JAK2V617F‐dependent down regulation of SHP‐1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF‐β
Céline Aoun, Nabih Maslah, Saravanan Ganesan, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 20
Open Access | Times Cited: 2
The heat shock protein DNAJB2 as a novel biomarker for essential thrombocythemia diagnosis associated with immune infiltration
Hui Chen, Chao Lin, Hongman Xue, et al.
Thrombosis Research (2023) Vol. 223, pp. 131-138
Closed Access | Times Cited: 6
Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells
Julian Baumeister, Tiago Maié, Nicolas Chatain, et al.
Annals of Hematology (2021) Vol. 100, Iss. 12, pp. 2943-2956
Open Access | Times Cited: 14
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Fermín Person, Sara C. Meyer, Helmut Hopfer, et al.
Virchows Archiv (2021) Vol. 479, Iss. 5, pp. 1013-1020
Open Access | Times Cited: 13
Platelet Heterogeneity in Myeloproliferative Neoplasms
Sally Thomas, Anandi Krishnan
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 11, pp. 2661-2670
Open Access | Times Cited: 13
Resident Self-Tissue of Proinflammatory Cytokines Rather Than Their Systemic Levels Correlates with Development of Myelofibrosis in Gata1low Mice
Maria Zingariello, Paola Verachi, Francesca Gobbo, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 234-234
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top